A detailed history of Two Sigma Securities, LLC transactions in Recursion Pharmaceuticals, Inc. stock. As of the latest transaction made, Two Sigma Securities, LLC holds 42,457 shares of RXRX stock, worth $234,362. This represents 0.03% of its overall portfolio holdings.

Number of Shares
42,457
Previous 26,964 57.46%
Holding current value
$234,362
Previous $142,000 50.7%
% of portfolio
0.03%
Previous 0.02%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2025

Aug 14, 2025

BUY
$3.97 - $5.84 $61,507 - $90,479
15,493 Added 57.46%
42,457 $214,000
Q1 2025

May 15, 2025

BUY
$5.29 - $10.87 $142,639 - $293,098
26,964 New
26,964 $142,000

About RECURSION PHARMACEUTICALS, INC.


  • Ticker RXRX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 180,480,000
  • Market Cap $996M
  • Description
  • Recursion Pharmaceuticals, Inc. operates as a clinical-stage biotechnology company, engages in the decoding biology by integrating technological innovations across biology, chemistry, automation, data science, and engineering to industrialize drug discovery. The company develops REC-994, which is in Phase IIa clinical trial to treat cerebral cav...
More about RXRX
Track This Portfolio

Track Two Sigma Securities, LLC Portfolio

Follow Two Sigma Securities, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Two Sigma Securities, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Two Sigma Securities, LLC with notifications on news.